CUV fundamentals
Clinuvel Pharmaceuticals Limited financial statements, including revenue, expenses, and profit
The total revenue of CUV for the last semiannual is 59.37 M AUD, and it's 66.56% higher compared to the previous semiannual. The net income of H2 25 is 22.10 M AUD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: AUD
TTM